Application note Optimizing endotoxin removal with EtoxiClear® adsorbent Endotoxin from bacterial expression cells lines, such as E.coli, pose a critical challenge in biopharmaceutical purification, requiring strict control in final products. EtoxiClear® captures endotoxin in flow-through mode under flexible pH and salt conditions, minimizing protein loss. This application note describes a simple, cost-effective method using SPE columns and a vacuum manifold to optimize endotoxin removal.
Endotoxin, composed of lipopolysaccharides (LPS) derived from the cell wall of Gram-negative bacteria such as E. coli, represents a major challenge in the purification of biopharmaceuticals produced in bacterial systems. Contamination can also arise from external sources, meaning even non-bacterial expression systems are vulnerable. Endotoxins can trigger strong immune responses in patients, and therefore biotherapeutics are subject to stringent regulatory testing, with intravenous products required to remain below 5 EU/kg of patient body weight[1]. EtoxiClear® is a mixed-mode adsorbent specifically developed for its ability to bind endotoxin. Operated in flow-through mode, EtoxiClear® binds endotoxin molecules in the sample, while allowing the desired therapeutic protein to pass through. Unlike traditional ion-exchange adsorbents, EtoxiClear® has multiple bonding interactions, enabling endotoxin binding even at higher NaCl concentrations. This flexibility allows process conditions (pH and NaCl) to be tuned so that endotoxin removal is maximized, while target protein binding is minimized.
By combining EtoxiClear®’s robust binding properties with an efficient small-scale DoE workflow, bioprocess developers gain a practical tool to accelerate optimization of endotoxin removal, ensuring product safety and regulatory compliance while conserving time and resources.
Methods
Experiment design DOE software was used to plan a 2-level full factorial design with three factors (NaCl concentration, pH, and endotoxin load concentration). Bovine Serum Albumin (BSA) was used as a model target protein and control standard endotoxin (Associates of Cape Cod E0125) was used to spike samples to a set endotoxin concentration. The responses were target protein (BSA) recovery and endotoxin log reduction.
Identifying the best pH & salt conditions for a given protein system can be complicated by the risk of contamination during testing. For example, FPLC systems ideally require the flow path to be fully depyrogenated between runs to prevent cross contamination. While automated liquid handling systems offer the benefit of speed and high throughput testing, the aerosols generated in the enclosed equipment space can contaminate open buffer reservoirs with endotoxin. These practical hurdles can slow development and add unnecessary cost. To overcome these challenges, a simple and cost-effective method for parallel screening of pH and NaCl conditions has been developed using SPE columns and a vacuum manifold. This design of experiment (DoE) approach allows rapid, systematic testing without the complexity of large-scale instrumentation. Moreover, the method is fully compatible with gravity flow setups, making it accessible to a wide range of labs (Figure 1).
Figure 1: Biotage® VacMaster™ vacuum manifold for parallel column screening.